Biomarkers for treatment outcome in newly diagnosed epilepsy
Introduction and aims Epilepsy is a common neurological condition and around 25% of patients are resistant to treatment with currently available drugs (Brodie et al., 2012). Currently there is only a limited ability to predict treatment outcome and no genome based biomarkers for treatment efficacy....
Main Author: | Auce, P. |
---|---|
Other Authors: | Sills, G. J. ; Marson, A. G. M. ; Jorgensen, A. J. |
Published: |
University of Liverpool
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.722053 |
Similar Items
-
A prospective advanced magnetic resonance imaging study of newly diagnosed epilepsy
by: Alonazi, B. K.
Published: (2017) -
Studies of biomarkers in temporal lobe epilepsy
by: Sheilabi, Marim Abdelghani
Published: (2016) -
Epilepsy : its care and treatment
by: Garden, William S.
Published: (1908) -
AMPA receptors in the development and treatment of epilepsy
by: Williams, S. L.
Published: (2017) -
Epilepsy
by: McCallum, A. J.
Published: (1908)